FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
Tidmarsh's areas of expertise include pediatrics, pediatric oncology, and neonatology
Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
Six or nine months of bedaquiline, delamanid, linezolid, and clofazimine was not noninferior to longer standard of care
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab
Older age, Black race, very low Child Opportunity Index, public insurance linked to lower rates of nirsevimab receipt
Urgent Care Visits Often Linked to Inappropriate Prescribing
Overall, 12.4, 9.1, and 1.3 percent of urgent care visits led to antibiotic, glucocorticoid, and opioid prescription fills, respectively
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester
Newer Antiseizure Medications Less Likely to Be Associated With Major Malformations in Infants
Maternal use of valproate, phenobarbital, and topiramate early in pregnancy linked to increased risk versus lamotrigine use
Oral Ondansetron Beneficial for Pediatric Gastroenteritis-Linked Vomiting
Lower risk for moderate-to-severe gastroenteritis seen during seven days after enrollment with oral ondansetron versus placebo
